Cargando…
Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients?
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687383/ https://www.ncbi.nlm.nih.gov/pubmed/33460953 http://dx.doi.org/10.1016/j.retram.2020.103273 |
| _version_ | 1783613505610448896 |
|---|---|
| author | Alsuliman, Tamim Faict, Sylvia Malard, Florent Genthon, Alexis Brissot, Eolia Van de Wyngaert, Zoé Ikhlef, Souhila Banet, Anne Lapusan, Simona Sestili, Simona Corre, Elise M’hammedi-Bouzina, Fella Schaeffer, Louis Legrand, Ollivier Dulery, Rémy Mohty, Mohamad Marjanovic, Zora |
| author_facet | Alsuliman, Tamim Faict, Sylvia Malard, Florent Genthon, Alexis Brissot, Eolia Van de Wyngaert, Zoé Ikhlef, Souhila Banet, Anne Lapusan, Simona Sestili, Simona Corre, Elise M’hammedi-Bouzina, Fella Schaeffer, Louis Legrand, Ollivier Dulery, Rémy Mohty, Mohamad Marjanovic, Zora |
| author_sort | Alsuliman, Tamim |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7687383 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76873832020-11-25 Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients? Alsuliman, Tamim Faict, Sylvia Malard, Florent Genthon, Alexis Brissot, Eolia Van de Wyngaert, Zoé Ikhlef, Souhila Banet, Anne Lapusan, Simona Sestili, Simona Corre, Elise M’hammedi-Bouzina, Fella Schaeffer, Louis Legrand, Ollivier Dulery, Rémy Mohty, Mohamad Marjanovic, Zora Curr Res Transl Med Letter to the Editor Elsevier Masson SAS. 2021-01 2020-11-25 /pmc/articles/PMC7687383/ /pubmed/33460953 http://dx.doi.org/10.1016/j.retram.2020.103273 Text en © 2020 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Alsuliman, Tamim Faict, Sylvia Malard, Florent Genthon, Alexis Brissot, Eolia Van de Wyngaert, Zoé Ikhlef, Souhila Banet, Anne Lapusan, Simona Sestili, Simona Corre, Elise M’hammedi-Bouzina, Fella Schaeffer, Louis Legrand, Ollivier Dulery, Rémy Mohty, Mohamad Marjanovic, Zora Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients? |
| title | Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients? |
| title_full | Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients? |
| title_fullStr | Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients? |
| title_full_unstemmed | Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients? |
| title_short | Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients? |
| title_sort | does ibrutinib impact outcomes of viral infection by sars-cov-2 in mantle cell lymphoma patients? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687383/ https://www.ncbi.nlm.nih.gov/pubmed/33460953 http://dx.doi.org/10.1016/j.retram.2020.103273 |
| work_keys_str_mv | AT alsulimantamim doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients AT faictsylvia doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients AT malardflorent doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients AT genthonalexis doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients AT brissoteolia doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients AT vandewyngaertzoe doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients AT ikhlefsouhila doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients AT banetanne doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients AT lapusansimona doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients AT sestilisimona doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients AT correelise doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients AT mhammedibouzinafella doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients AT schaefferlouis doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients AT legrandollivier doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients AT duleryremy doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients AT mohtymohamad doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients AT marjanoviczora doesibrutinibimpactoutcomesofviralinfectionbysarscov2inmantlecelllymphomapatients |